Kehagias, P.; Kindt, N.; Krayem, M.; Najem, A.; Agostini, G.; Acedo Reina, E.; Bregni, G.; Sclafani, F.; Journe, F.; Awada, A.;
et al. Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance. Cells 2022, 11, 3663.
https://doi.org/10.3390/cells11223663
AMA Style
Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A,
et al. Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance. Cells. 2022; 11(22):3663.
https://doi.org/10.3390/cells11223663
Chicago/Turabian Style
Kehagias, Pashalina, Nadège Kindt, Mohammad Krayem, Ahmad Najem, Giulia Agostini, Elena Acedo Reina, Giacomo Bregni, Francesco Sclafani, Fabrice Journe, Ahmad Awada,
and et al. 2022. "Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance" Cells 11, no. 22: 3663.
https://doi.org/10.3390/cells11223663
APA Style
Kehagias, P., Kindt, N., Krayem, M., Najem, A., Agostini, G., Acedo Reina, E., Bregni, G., Sclafani, F., Journe, F., Awada, A., Ghanem, G. E., & Hendlisz, A.
(2022). Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance. Cells, 11(22), 3663.
https://doi.org/10.3390/cells11223663